ChiCTR2300067883 版本V1.0 版本创建时间2023/01/30 15:09:11 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2300067883 

最近更新日期:

Date of Last Refreshed on:

2023-01-30 15:07:47 

注册时间:

Date of Registration:

2023-01-30 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

术前多模态虚拟现实干预对非心脏手术患者谵妄发生率的影响

Public title:

The effect of multi -modal virtual reality intervention on the incidence of delirium in patients with non-cardiac surgery

注册题目简写:

English Acronym:

研究课题的正式科学名称:

康复医学

Scientific title:

Rehabilitation medicine

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

罗文君 

研究负责人:

朱斌斌 

Applicant:

Luo Wenjun 

Study leader:

Zhu Binbin 

申请注册联系人电话:

Applicant telephone:

18692056610

研究负责人电话:

Study leader's
telephone:

15957485723

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

luowenjun1224@163.com

研究负责人电子邮件:

Study leader's E-mail:

pingchi1983@126.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

宁波市江北区人民路247号

研究负责人通讯地址:

宁波市江北区人民路247号

Applicant address:

247 Renmin Road, Jiangbei District, Ningbo, Zhejiang

Study leader's address:

247 Renmin Road, Jiangbei District, Ningbo, Zhejiang

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

宁波大学医学院附属医院

Applicant's institution:

the Affiliated Hospital of Medical School of Ningbo University

研究负责人所在单位:

宁波大学医学院附属医院

Affiliation of the Leader:

the Affiliated Hospital of Medical School of Ningbo University

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

2022KY085

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

宁波大学医学院附属医院伦理委员会

Name of the ethic committee:

Ethics Committee of Affiliated Hospital of Medical Schoolof Ningbo University

伦理委员会批准日期:

Date of approved by ethic committee:

2022-12-29 00:00:00

伦理委员会联系人:

周玉平

Contact Name of the ethic committee:

Zhou Yuping

伦理委员会联系地址:

宁波市江北区人民路247号

Contact Address of the ethic committee:

247 Renmin Road, Jiangbei District, Ningbo, Zhejiang

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

宁波大学医学院附属医院

Primary sponsor:

the Affiliated Hospital of Medical School of Ningbo University

研究实施负责(组长)单位地址:

宁波市江北区人民路247号

Primary sponsor's address:

247 Renmin Road, Jiangbei District, Ningbo, Zhejiang

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

浙江

市(区县):

江北区

Country:

China

Province:

Zhejiang

City:

Jiangbei District

单位(医院):

宁波大学医学院附属医院

具体地址:

人民路247号

Institution
hospital:

The Affiliated Hospital of Medical School of Ningbo University

Address:

247 Renmin Road

经费或物资来源:

宁波市科技局

Source(s) of funding:

Ningbo Science and Technology Bureau

研究疾病:

术后谵妄  

Target disease:

Postoperative delirium

研究疾病代码:

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

探索性研究/预试验 

Study phase:

0

研究设计:

随机平行对照 

Study design:

Parallel 

研究目的:

通过多模态虚拟现实,将芳香疗法与亲生态虚拟现实结合,从视觉、听觉、嗅觉多维度缓解焦虑水平,从而减少术后谵妄的发生率。  

Objectives of Study:

With multimodal virtual reality, it is the combination of aromatherapy and biophilic virtual reality that reduces the incidence of post-operative delirium by alleviating anxiety levels in a multidimensional way from visual, auditory and olfactory senses.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

a. 在本院进行非心脏手术的患者(肝胆外科、骨外科、胃肠外科、泌尿外科等); b.年龄≥60岁;c. 因手术而感到焦虑患者(Hospital Anxiety and Depression Scale Anxiety 大于7分);d.预计手术时长≥2小时;e.预计手术后住院时间≥3天

Inclusion criteria

a. Patients undergoing non-cardiac surgery in our hospital (hepatobiliary, orthopedic, gastrointestinal, urological, etc.); b. Age ≥ 60 years; c. Patients with anxiety due to surgery (Hospital Anxiety and Depression Scale Anxiety score greater than 7); d. Expected duration of surgery ≥ 2 hours; e. Expected length of stay after surgery ≥ 3 days

排除标准:

a. 无法沟通/神经疾病/脑损伤病史; b. 术前存在抑郁症病史;c. 严重的视觉/听觉/嗅觉障碍;d.对精油过敏

Exclusion criteria:

a. History of inability to communicate/neurological disease/brain injury. b. history of preoperative depression. c. Severe visual/auditory/smell impairment. d. Allergy to essential oils

研究实施时间:

Study execute time:

From 2023-02-01 00:00:00 To 2024-01-31 00:00:00  

征募观察对象时间:

Recruiting time:

From 2023-02-01 00:00:00 To 2024-01-31 00:00:00

干预措施:

Interventions:

组别:

多模态虚拟现实眼镜组

样本量:

86

Group:

Multimodal virtual reality group

Sample size:

干预措施:

佩戴虚拟现实眼镜及进行芳香疗法20分钟

干预措施代码:

Intervention:

At the same time, wear virtual reality glasses and perform aromatherapy, intervention time is 20 minutes

Intervention code:

组别:

亲生态虚拟现实组

样本量:

86

Group:

Biophilic virtual reality group

Sample size:

干预措施:

佩戴亲生态虚拟现实眼镜20分钟

干预措施代码:

Intervention:

Wearing biophilic virtual reality glasses for 20 minutes

Intervention code:

组别:

芳香疗法组

样本量:

86

Group:

Aromatherapy group

Sample size:

干预措施:

进行芳香疗法20分钟

干预措施代码:

Intervention:

20 minutes for aromatherapy

Intervention code:

组别:

空白对照组

样本量:

86

Group:

Blank control group

Sample size:

干预措施:

没有干预措施

干预措施代码:

Intervention:

No intervention

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

浙江 

市(区县):

宁波 

Country:

China

Province:

Zhejiang

City:

Ningbo

单位(医院):

宁波大学医学院附属医院 

单位级别:

三级甲等 

Institution
hospital:

The Affiliated Hospital of Medical School of Ningbo University

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

术后7天谵妄发生率

指标类型:

主要指标

Outcome:

Incidence of delirium 7 days

Type:

Primary indicator

测量时间点:

术后至出院前的每一天

测量方法:

三分钟谵妄诊断量表 (3D-CAM)

Measure time point of outcome:

Every day after surgery until discharge

Measure method:

Three Minute Delirium Diagnostic Scale

指标中文名:

术后谵妄持续时间

指标类型:

次要指标

Outcome:

Duration of postoperative delirium

Type:

Secondary indicator

测量时间点:

术后至出院前的每一天

测量方法:

三分钟谵妄诊断量表 (3D-CAM)

Measure time point of outcome:

Every day after surgery until discharge

Measure method:

Three Minute Delirium Diagnostic Scale

指标中文名:

术后谵妄严重程度

指标类型:

次要指标

Outcome:

Severity of postoperative delirium

Type:

Secondary indicator

测量时间点:

术后至出院前的每一天

测量方法:

谵妄评定量表98修订版 (DRS.R-98)

Measure time point of outcome:

Every day after surgery until discharge

Measure method:

Delirium Rating Scale 98 Revised

指标中文名:

干预后焦虑评分

指标类型:

次要指标

Outcome:

Post-intervention anxiety scores

Type:

Secondary indicator

测量时间点:

完成干预后

测量方法:

6项状态特质焦虑量表 (6-STAI)和阿姆斯特丹术前焦虑与信息需求量表 (APAIS);

Measure time point of outcome:

After the intervention

Measure method:

6-Item State Trait Anxiety Inventory and Amsterdam Preoperative Anxiety and Information Needs Inventory

指标中文名:

干预前后血压差值

指标类型:

次要指标

Outcome:

Difference in blood pressure before and after intervention

Type:

Secondary indicator

测量时间点:

干预前及干预后

测量方法:

多功能心电监护仪

Measure time point of outcome:

Pre- and post-intervention

Measure method:

Multifunctional electrocardiograph (ECG) monitor

指标中文名:

干预前后心率差值

指标类型:

次要指标

Outcome:

Heart rate difference before and after intervention

Type:

Secondary indicator

测量时间点:

干预前及干预后

测量方法:

多功能心电监护仪

Measure time point of outcome:

Pre- and post-intervention

Measure method:

Multifunctional ECG monitor

指标中文名:

术后疼痛水平

指标类型:

次要指标

Outcome:

Post-operative pain levels

Type:

Secondary indicator

测量时间点:

术后当天

测量方法:

视觉模拟量表

Measure time point of outcome:

Day after surgery

Measure method:

visual analogue scale

指标中文名:

干预前焦虑水平

指标类型:

次要指标

Outcome:

Pre-intervention anxiety levels

Type:

Secondary indicator

测量时间点:

干预前

测量方法:

医院焦虑抑郁量表

Measure time point of outcome:

Pre-intervention

Measure method:

Hospital Anxiety and Depression Scale

指标中文名:

术前疼痛水平

指标类型:

次要指标

Outcome:

Pre-operative pain levels

Type:

Secondary indicator

测量时间点:

干预前

测量方法:

视觉模拟量表

Measure time point of outcome:

Pre-intervention

Measure method:

visual analogue scale

采集人体标本:

Collecting sample(s)
from participants:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 60 years
最大 Max age years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

采用分层区组随机化实现随机分组:样本量344,分组比例1:1 : 1 : 1,区组长度8,分层因子为术前是否存在疼痛

Randomization Procedure (please state who generates the random number sequence and by what method):

Randomization of layered district groups to achieve random grouping: sample volume 344, group ratio 1: 1: 1, district group length 8, layered factors whether there are pain before surgery

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

Blinding:

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

否No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

不共享原始数据

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

No

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

采用电子病历记录表格

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Case Record Form

数据与安全监察委员会:

Data and Safety Monitoring Committee:

有/Yes

注册人:

Name of Registration:

 2023-01-30 15:07:47